Featured Research

from universities, journals, and other organizations

Colon Cancer Screening: Going 'Back To The Future'?

Date:
February 27, 2007
Source:
Indiana University
Summary:
Colon cancer screening rates continue to lag behind those for breast and cervical cancer. In an editorial in the February 20 edition of the Annals of Internal Medicine, Indiana University School of Medicine gastroenterologist and Regenstrief Institute, Inc. researcher Thomas Imperiale, M.D., writes that to increase screening rates for colorectal cancers, we need more convenient and less invasive screening tests. An infrequently used type of fecal sampling test, which has had Federal Drug Administration approval since 2001, may meet that need he says.

Colon cancer screening rates continue to lag behind those for breast and cervical cancer. In an editorial in the Feb. 20 edition of the Annals of Internal Medicine, Indiana University School of Medicine gastroenterologist and Regenstrief Institute, Inc. researcher Thomas Imperiale, M.D., writes that to increase screening rates for colorectal cancers, we need more convenient and less invasive screening tests. An infrequently used type of fecal sampling test, which has had Federal Drug Administration approval since 2001, may meet that need he says.

"In recent years, use of non-invasive screening has declined in favor of colonoscopy, but not everyone is willing to have a colonoscopy," said Dr. Imperiale, who is an IU School of Medicine professor of medicine. "The new immunochemical fecal occult blood test, referred to as I-FOBT, is a significant improvement over the older guaiac-based version. The newer fecal test has the potential to substantially increase screening rates for colorectal cancer, taking us back to the future in a sense." said Dr. Imperiale.

Unlike traditional fecal sampling tests which do not differentiate between blood from diet and blood from the digestive tract, I-FOBT uses antibodies to detect human blood in stool. This increased test specificity eliminates the need for dietary restrictions before colon cancer screening which may induce some individuals who are otherwise unwilling to take a screening test to do so.

Perhaps more importantly, the ability to choose different thresholds to indicate a positive result makes I-FOBT a test that can be used for individuals of any risk. "The test output (amount of hemoglobin per gram of stool) is a continuous variable, which means that a clinician can choose an I-FOBT positivity threshold to suit the patient's clinical characteristics such as age and reduce the chance of false positive test result," says Dr. Imperiale.

There are only a few examples of truly good screening tests for any cancer, according to Dr. Imperiale. He says that PAP smears are probably the best currently available screening tools because they are reasonably sensitive, specific and inexpensive, and the test itself has no risk. I-FOBT may be the comparable test for colon cancer screening, he concludes.

Colorectal cancer is the third most common cancer and the third leading cause of cancer related deaths in the United States. The National Cancer Institute estimates that more than 52,000 American will die of colorectal cancer in 2007.


Story Source:

The above story is based on materials provided by Indiana University. Note: Materials may be edited for content and length.


Cite This Page:

Indiana University. "Colon Cancer Screening: Going 'Back To The Future'?." ScienceDaily. ScienceDaily, 27 February 2007. <www.sciencedaily.com/releases/2007/02/070220012916.htm>.
Indiana University. (2007, February 27). Colon Cancer Screening: Going 'Back To The Future'?. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2007/02/070220012916.htm
Indiana University. "Colon Cancer Screening: Going 'Back To The Future'?." ScienceDaily. www.sciencedaily.com/releases/2007/02/070220012916.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins